euphausia superba oil

Reported Uses

• NOTE: see Herb & Supplement Effectiveness Rating Definitions table
• aging skin [Insufficient Evidence]
• Alzheimer dementia [Insufficient Evidence]
• cancer prevention [Insufficient Evidence]
• cardiovascular disease [Insufficient Evidence]
• cognitive function [Insufficient Evidence]
• depression [Insufficient Evidence]
• diabetes mellitus, type 2 [Insufficient Evidence]
• dry eye disease [Possibly Effective]
• dysmenorrhea [Insufficient Evidence]
• exercise-induced muscle damage [Insufficient Evidence]
• HTN [Insufficient Evidence]
• hyperlipidemia [Insufficient Evidence]
• hypertriglyceridemia [Insufficient Evidence]
• obesity [Insufficient Evidence]
• osteoarthritis [Insufficient Evidence]
• Parkinson disease [Insufficient Evidence]
• premenstrual syndrome [Insufficient Evidence]
• rheumatoid arthritis [Insufficient Evidence]
• sarcopenia [Insufficient Evidence]
• stroke [Insufficient Evidence]

Reported Doses

Safety/efficacy may not be established; reported doses may be derived from limited or potentially inadequate studies with variable regimens, multi-ingredient products, or where concentration of active ingredients may vary widely

Effectiveness Ratings

[see Herb & Supplement Effectiveness Rating Definitions table]

Special Note

[formulation clarification]

Info: krill oil products contain varying amounts of omega fatty acids, such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)

aging skin

[Insufficient Evidence]

Dose: 200 mg krill oil PO tid

dry eye disease

[Possibly Effective]

Dose: 945 mg EPA and 510 mg DHA PO qd

dysmenorrhea

[Insufficient Evidence]

Dose: 2 g krill oil PO qd

exercise-induced muscle damage

[Insufficient Evidence]

Dose: 3 g krill oil providing 360 mg EPA and 210 mg DHA PO qd

hyperlipidemia

[Insufficient Evidence]

Dose: 1-3 g krill oil PO qd

hypertriglyceridemia

[Insufficient Evidence]

Dose: 0.5-4 g/day krill oil PO divided qd-bid

osteoarthritis

[Insufficient Evidence]

Dose: 4 g krill oil providing 0.6 g EPA and 0.28 g DHA PO qd; Alt: 0.3 g krill oil PO qd

premenstrual syndrome

[Insufficient Evidence]

Dose: 0.7-2 g krill oil PO qd

rheumatoid arthritis

[Insufficient Evidence]

Dose: 300 mg krill oil PO qd

sarcopenia

[Insufficient Evidence]

Dose: 2 g krill oil providing 772 mg EPA and 384 mg DHA PO bid